13
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Autoantibodies to the Protein Core of Vascular Basement Membrane Heparan Sulfate Proteoglycan in Systemic Lupus Erythematosus

, , , , &
Pages 243-249 | Received 10 Jul 1992, Accepted 13 Oct 1992, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maja Matic, Shinobu Shibata & Howard M. Fillit. (1997) Monoclonal antibody to heparan sulfate from autoimmune tight skin (TSK) mice binds to the endothelial cell surface. Immunological Investigations 26:3, pages 371-381.
Read now

Articles from other publishers (24)

Balázs Sonkodi, László Marsovszky, Anita Csorba, Attila Balog, Bence Kopper, Zoltán Zsolt Nagy & Miklós D. Resch. (2023) Neural Regeneration in Dry Eye Secondary to Systemic Lupus Erythematosus Is Also Disrupted like in Rheumatoid Arthritis, but in a Progressive Fashion. International Journal of Molecular Sciences 24:13, pages 10680.
Crossref
Julia Y. Wang, Wei Zhang, Victor B. Roehrl, Michael W. Roehrl & Michael H. Roehrl. (2022) An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19. Frontiers in Immunology 13.
Crossref
Julia Y. Wang, Wei Zhang, Michael W. Roehrl, Victor B. Roehrl & Michael H. Roehrl. (2021) An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19. Journal of Autoimmunity 120, pages 102644.
Crossref
Wei Zhang, Jung-hyun Rho, Michael H. Roehrl & Julia Y. Wang. (2019) A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins. BMC Immunology 20:1.
Crossref
Manuela Velásquez, Mauricio Rojas, Vikki M. Abrahams, Carlos Escudero & Ángela P. Cadavid. (2018) Mechanisms of Endothelial Dysfunction in Antiphospholipid Syndrome: Association With Clinical Manifestations. Frontiers in Physiology 9.
Crossref
P. Piotrowski, M. Lianeri, M. Mostowska, M. Wudarski, H. Chwalińska-Sadowska & PP Jagodziński. (2008) Contribution of polymorphism in codon 72 of p53 gene to systemic lupus erythematosus in Poland. Lupus 17:2, pages 148-151.
Crossref
Piotr C. Piotrowski, Sergiusz Duriagin & Paweł P. Jagodzinski. (2005) Expression of human endogenous retrovirus clone 4-1 may correlate with blood plasma concentration of anti-U1 RNP and anti-Sm nuclear antibodies. Clinical Rheumatology 24:6, pages 620-624.
Crossref
Yaniv Sherer, Alexander Gorstein, Marvin J. Fritzler & Yehuda Shoenfeld. (2004) Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Seminars in Arthritis and Rheumatism 34:2, pages 501-537.
Crossref
Joan T. Merrill. 2004. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 1161 1184 .
Joan T. Merrill. (2003) The antiphospholipid syndrome and atherosclerosis: Clue to pathogenesis. Current Rheumatology Reports 5:5, pages 401-406.
Crossref
Martin Herrmann, Reinhard E. Voll, Udo Gaipl, Wasilis Kolowos & Joachim R. Kalden. 2003. Molekularmedizinische Grundlagen von rheumatischen Erkrankungen. Molekularmedizinische Grundlagen von rheumatischen Erkrankungen 291 313 .
Joan T. Merrill. (2001) WHICH ANTIPHOSPHOLIPID ANTIBODY TESTS ARE MOST USEFUL?. Rheumatic Disease Clinics of North America 27:3, pages 525-549.
Crossref
Joan T. Merrill. (2001) What causes the antiphospholipid syndrome?. Current Rheumatology Reports 3:4, pages 293-300.
Crossref
V Strand. (2016) Monoclonal antibodies and other biologic therapies. Lupus 10:3, pages 216-221.
Crossref
Robert Roubey. 2001. Vascular Manifestations of Systemic Autoimmune Diseases. Vascular Manifestations of Systemic Autoimmune Diseases.
Vibeke Strand. (2000) NEW THERAPIES FOR SYSTEMIC LUPUS ERYTHEMATOSUS. Rheumatic Disease Clinics of North America 26:2, pages 389-406.
Crossref
Joan T. Merrill. (2000) Clinical trials for the antiphospholipid syndrome. Current Rheumatology Reports 2:3, pages 233-237.
Crossref
Vibeke Strand. (1999) Biologic agents and innovative interventional approaches in the management of systemic lupus erythematosus. Current Opinion in Rheumatology 11:5, pages 330-340.
Crossref
J.R. Kalden, M. Hermann & Th. Winkler. 1999. The Decade of Autoimmunity. The Decade of Autoimmunity 85 93 .
Robert A. S. Roubey. 1999. Lupus. Lupus 471 491 .
Bruce Gaynor, Chaim Putterman, Philippe Valadon, Linda Spatz, Matthew D. Scharff & Betty Diamond. (1997) Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proceedings of the National Academy of Sciences 94:5, pages 1955-1960.
Crossref
Robert A. S. Roubey. (2005) Immunology of the antiphospholipid antibody syndrome. Arthritis & Rheumatism 39:9, pages 1444-1454.
Crossref
Robert A. S. Roubey. 1995. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 81 92 .
Jeanette H. Magnus, Tore Stenstad & Gunnar Husby. (1994) Proteoglycans, glycosaminoglycans and amyloid deposition. Baillière's Clinical Rheumatology 8:3, pages 575-597.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.